Generics Industry Flags Up 'Duplication' And 'Redundancies' In EU Regulatory Systems
This article was originally published in SRA
Executive Summary
Over the 50 years that the EU pharmaceutical legislation has been in place, great progress has been made in terms of improving the quality, safety and efficacy of medicines, and a significant effort has been expended in building a strong European regulatory structure and harmonized European standards.